Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2021
Home
2021
June 8, 2021
Published by
Dominic Burg
on
June 8, 2021
Categories
Supply Agreement for Cellmid’s FGF5 Inhibitors
May 3, 2021
Published by
Dominic Burg
on
May 3, 2021
Categories
Investor Briefing and Presentation
April 30, 2021
Published by
Dominic Burg
on
April 30, 2021
Categories
Chinese Import Permits Received
April 29, 2021
Published by
Dominic Burg
on
April 29, 2021
Categories
Investor Briefing
April 29, 2021
Published by
Dominic Burg
on
April 29, 2021
Categories
Agreement Signed for Sale of Lyramid Limited
April 23, 2021
Published by
Dominic Burg
on
April 23, 2021
Categories
Appendix 4C and Quarterly Activity Report
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Change of Director’s Interest Notice – Eck
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Change of Director’s Interest Notice – Cross
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Change of Director’s Interest Notice – Halasz
Prev page
1
2
3
4
5
6
7
Next page
